Recent research quantifies how systemic inflammation, measured by CRP and immune cells, contributes to mortality risk in older adults, with strong implications for diabetes care. A new large-scale stu...
New economic analysis from the WEF and Nature Aging shows that extending healthy lifespan could yield trillions in annual gains, but only if anti-aging therapies are made universally accessible, not j...
A new biomarker derived from the Framingham Heart Study measures the speed of biological decline, offering a more sensitive endpoint for anti-aging clinical trials. A rate-based biomarker from the Fra...
A Nature Aging study found that centenarians harbor Clostridium scindens, which produces indole-3-acetic acid, restoring gut barrier integrity in aged mice and offering new targets for healthy aging t...
Researchers combine dichloroacetate and metformin with a 10-fold lower Navitoclax dose, selectively clearing senescent cells while limiting platelet toxicity and advancing clinical senolytic use. A ne...
Senomorphic drugs aim to tame the harmful effects of senescent cells without killing them, offering a more targeted approach to age-related diseases. A new wave of drugs called senomorphics could chan...
New breakthroughs in understanding the brain’s waste-clearing glymphatic system are opening doors to novel Alzheimer’s and Parkinson’s interventions, from lifestyle tweaks to future ...
A new framework, inflammatory fidelity, shifts the focus from blanket anti-inflammatory measures to the precision of immune responses, offering a deeper path to healthy aging and individualized longev...
Moving off legacy software without losing client data, bookings or search rankings is a discipline, not a leap. A concrete checklist: inventory your data and integrations, preserve client history, mig...
Older incumbents genuinely have more accumulated features and edge cases — concede it. The sharper question for a wellness business is which problem you'd rather own: compounding cost and un-ownable...